Federal Trade Commission accuses three drug middlemen of …
WEB1 day ago · The FTC accused the "Big Three" pharmacy benefit managers (PBMs) — UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts — of "engaging in anticompetitive and unfair ...
FTC Sues Prescription Drug Middlemen for Artificially Inflating …
WEB1 day ago · Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs, impaired patients’ access to lower ...
Federal Trade Commission sues largest drug middlemen for …
WEB1 day ago · The Federal Trade Commission alleges CVS Health’s Caremark Rx, Cigna’s Express Scripts and United Health Group’s OptumRx created a system that prioritizes high rebates from drug ...
FTC sues insulin middlemen, saying they pocket ... - Health News …
WEB4 hours ago · The FTC brought action against the top PBMs — CVS Health's Caremark Rx, Cigna's Express Scripts, and United Health Group's OptumRx — saying the companies created a "perverse drug rebate system" that artificially inflates the cost of insulin. If the suit is successful, it could further drive down costs for patients at the pharmacy counter.
Drug middlemen illegally drive up the cost of insulin, FTC says
WEB1 day ago · The companies — CVS-owned Caremark Rx, Cigna Group's Express Scripts and UnitedHealth Group's Optum Rx — acted in ways that stifled industry competition for insulin drugs, including by using ...
FTC sues OptumRx, rivals over insulin pricing - Star Tribune
WEB1 day ago · The administrative complaint alleges that Caremark Rx, Express Scripts and Optum Rx — dubbed the “Big Three” of pharmacy benefit managers — worked with their respective group purchasing ...
FTC sues CVS, Cigna, UnitedHealth PBMs over insulin prices - STAT
WEB1 day ago · The administrative complaint accused CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx of creating a “perverse” system of rebates that favored insulin that was sold at ...
Federal Trade Commission to sue three largest PBMs: WSJ
WEBJul 10, 2024 · Antitrust regulators are poised to file suit against CVS Caremark, Express Scripts and Optum Rx over how they negotiate discounts for drugs, including insulin, according to the report.
Express Scripts Comments on FTC's Reckless Insulin Action - PR …
WEB1 day ago · Express Scripts was the first to cap out-of-pocket costs for insulin medications at $25 for a 30-day supply in 2019, well before the government took action. ST. LOUIS, Sept. 20, 2024 /PRNewswire ...
Express Scripts sues FTC over report damning pharmacy benefit …
WEB5 days ago · Regulators also flagged significant concerns that just three companies hold oligopoly control of the market for PBM services: Express Scripts, CVS Caremark and UnitedHealth’s Optum Rx control 80 ...